Tumour enzyme affinity mediated peptide molecular crowding for targeted disruption of hyperactivated glucose uptake.

An unconventional environment-responsive molecular crowding specific binding between small molecule peptide inhibitor derivatives and an overexpressed tumour enzyme has been developed. Assemblies of such short peptides selectively localize on tumour surfaces and exhibited unique functions in disrupting hyperactivated glucose uptake, providing novel insights towards strategic tumour treatment.